Long-chain polyunsaturated fatty acids in memory formation and consolidation: Further evidence and discussion

Nutrition

Volumn 19, Issue 11-12, 2003, Pages 988-993

  Das, Undurti N ^a  

^a EFA Sciences LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; INSULIN; LONG CHAIN FATTY ACID; NEUROFIBROMIN; NITRIC OXIDE; POLYUNSATURATED FATTY ACID; RAS PROTEIN;

COGNITION; HUMAN; LONG TERM MEMORY; MEMORY; NEUROFIBROMATOSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0242412912     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0899-9007(03)00174-6     Document Type: Review

References (89)

1. Markowitsch H.J. Varieties of memory systems, structures, mechanisms of disturbance. Neurol Psychiatr Brain Res. 2:1997;49.
2. Fuster J.M. Distributed memory for both short- and long term. Neurobiol Learn Mem. 70:1998;268.
3. Goldman-Rakic P. Regional and cellular fractionation of working memory. Proc Natl Acad Sci USA. 93:1996;13473.
4. Lu B., Figurov A. Role of neurotrophins in synapse development and plasticity. Rev Neurosci. 8:1997;1.
5. Vetter M.L., Martin-Zanca D., Parada L.F., Bishop J.M., Kaplan D.R. Nerve growth factor rapidly stimulates tyrosine phosphorylation of phospholipase-gamma 1 by a kinase activity associated with the product of the trk protooncogene. Proc Natl Acad Sci USA. 88:1991;5650.
6. Ohmichi M., Decker S.J., Saltiel A.R. Activation of phosphatidylinositol 3′-kinase by nerve growth factor involves indirect coupling of the trk protooncogene with src homology 2 domains. Neuron. 9:1992;769.
7. Obermeier A., Lammers R., Wiesmuller K.H., Jung G., Schlessinger J., Ullrich A. Identification of Trk binding sites for SHC and phosphatidylinositol 3′-kinase and formation of a multimeric signaling complex. J Biol Chem. 268:1993;22963.
8. Stephens R.M., Loeb D.M., Copeland T.D., Pawson T., Greene L.A., Kaplan D.R. Trk receptors use redundant signal transduction pathways involving SHC and PLC-gamma 1 to mediate NGF response. Neuron. 12:1994;691.
9. Segal R.A., Greenberg M.E. Intracellular signaling pathways activated by neurotrophic factors. Annu Rev Neurosci. 19:1996;463.
10. Kaplan D.R., Stephens R.M. Neurotrophin signal transduction by the Trk receptor. J Neurobiol. 25:1994;1404.
11. Burgering B.M., Coffer P.J. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature. 376:1995;599.
12. Finkbeiner S., Tavazoie S.F., Maloratsky A., Jacobs K.M., Harris K.M., Greenberg M.E. CREB. A major mediator of neuronal neurotrophin responses. Neuron. 19:1997;1031.
13. Gottschalk W.A., Jiang H., Tartaglia N., Feng L., Figurov A., Lu B. Signaling mechanisms mediating BDNF modulation of synaptic plasticity in the hippocampus. Learn Mem. 6:1999;243.
14. Bernabeu R., Bevilaqua L., Ardenghi P., et al. Involvement of hippocampal D1/D5 receptor-cAMP signaling pathways in a late memory consolidation phase of an aversively-motivated task in rats. Proc Natl Acad Sci USA. 94:1997;7041.
15. Bernabeu R., Schroder N., Quevedo J., Cammarota M., Izquierdo I., Medina J.H. Further evidence for the involvement of a hippocampal Cgmp/Cgmp-dependent protein kinase cascade in memory consolidation. Neuroreport. 8:1997;2221.
16. Izquierdo I., Medina J.H. Memory formation the sequence of biochemical events in the hippocampus and its connections to activity in other brain structures . Neurobiol Learn Mem. 68:1997;285.
17. Vianna M.R.M., Izquierdo L.A., Barros D.M., Medina J.H., Izquierdo I. Intrahippocampal infusion of an inhibitor of protein kinase A separates short- from long-term memory. Behav Pharmacol. 10:1999;223.
18. Vianna M.R.M., Izquierdo L.A., Barros D.M., et al. Differential role of hippocampal cAMP-dependent protein kinase in short- and long-term memory. Neurochem Res. 25:2000;621.
19. Bhalla M., Iyengar R. Emergent properties of networks of biological signaling pathways. Science. 283:1999;381.
20. Lisma J.E., Fallon J.R. What maintain memories? Science. 283:1999;339.
21. Waltz R., Roesler R., Quevedo J., et al. Effects of post-training infusions of a mitogen-activated protein kinase kinase inhibitor into the hippocampus or entorhinal cortex on short- and long-term retention of inhibitory avoidance. Behav Pharmacol. 10:1999;723.
22. Walz R., Lenz G., Roesler R., et al. Time-dependent enhancement of inhibitory avoidance retention and MAPK activation by post-training infusion of nerve growth factor into CA1 region of hippocampus of adult rats. Eur J Neurosci. 12:2000;2185.
23. Levi-Montalcini R. The nerve growth factor 35 years later. Science. 237:1987;1154.
24. Waters S.B., Chen D., Kao A.W., Okada S., Holt K.H., Pessin J.E. Insulin and epidermal growth factor receptors regulate distinct pools of Grb2-SOS in the control of Ras activation. J Biol Chem. 271:1996;18224.
25. Mazzoni I.E., Said F.A., Aloyz R., Miller F.D., Kaplan D. Ras regulates sympathetic neuron survival by suppressing the p53-mediated cell death pathway. J Neurosci. 19:1999;9716.
26. 2+ and Ras signaling pathways. Biochim Biophys Acta. 1448:1998;171.
27. Orban P.C., Chapman P.F., Brambilla R. Is the Ras-MAPK signaling pathway necessary for long-term memory formation? Trends Neurosci. 22:1999;38.
28. Yun H.Y., Dawson V.L., Dawson T.M. Glutamate-stimulated calcium activation of Ras/Erk pathway mediated by nitric oxide. Diabetes Res Clin Pract. 45:1999;113.
29. Umanoff H., Edelmann W., Pellicer A., Raju K. The murine N-ras gene is not essential for growth and development. Proc Natl Acad Sci USA. 92:1995;1709.
30. Fernandez-Medarde A., Esteban L.M., Nunez A., Porteros A., Tessarollo L., Santos E. Targeted disruption of ras-grf2 shows its dispensability for mouse growth and development. Mol Cell Biol. 22:2002;2498.
31. Costa R.M., Yang T., Huynh D.P., et al. Learning deficits, but normal development and tumor predisposition, in mice lacking exon 23a of Nf1. Nat Genet. 27:2001;399.
32. Daston M.M., Scrable H., Nordlund M., Sturbaum A.K., Nissen L.M., Ratner N. The protein product of the neurofibromatosis type gene is expressed at highest abundance in neurons, Schwann cells, and oligodendrocytes. Neuron. 8:1992;415.
33. Pawson T. Protein modules and signaling networks. Nature. 373:1995;573.
34. Wasiak S., Quinn C.C., Ritter B., et al. The Ras/Rac guanine nucleotide exchange factor mammalian Son-of-sevenless interacts with PACSIN 1/Syndapin I, a regulator of endocytosis and the actin cytoskeleton. J Biol Chem. 276:2001;26622.
35. LeDoux J.E. Emotion clues from the brain . Annu Rev Psychol. 46:1995;209.
36. Maren S., Fanselow M.S. The amygdala and fear conditioning has the nut been cracked? Neuron. 16:1996;237.
37. Kim J.J., Fanselow M.S. Modality-specific retrograde amnesia of fear. Science. 256:1992;675.
38. 2+-dependent routes to Ras mechanisms for neuronal survival, differentiation, and plasticity? Neuron. 16:1996;233.
39. Brambilla R., Gnesutta N., Minichiello L., et al. A role for the Ras signaling pathway in synaptic transmission and long-term memory. Nature. 390:1997;281.
40. Giese K.P., Friedman E., Telliez J.B., et al. Hippocampus-dependent learning and memory is impaired in mice lacking the Ras-guanine-nucleotide releasing factor 1 (Ras-GRF1). Neuropharmacology. 41:2001;791.
41. Luo Y., Long J.M., Spangler E.L., Longo D.L., Ingram D.K., Weng N.P. Identification of maze learning-associated genes in rat hippocampus by cDNA microarray. J Mol Neurosci. 17:2001;397.
42. Barros D.M., Mello e Souza T., de Souza M.M., et al. LY294002, an inhibitor of phosphoinositide 3-kinase given into rat hippocampus impairs acquisition, consolidation and retrieval of memory for one-trial step-down inhibitory avoidance. Behav Pharmacol. 12:2001;629.
43. Orban P.C., Chapman P.F., Brambilla R. Is the Ras-MAPK signaling pathway necessary for long-term memory formation? Trends Neurosci. 22:1999;38.
44. Xue L., Murray J.H., Tolkovsky A.M. The Ras/phosphatidylinositol 3-kinase and Ras/ERK pathways function as independent survival modules each of which inhibits a distinct apoptotic signaling pathway in sympathetic neurons. J Biol Chem. 275:2000;8817.
45. Yun H.Y., Dawson V.L., Dawson T.M. Glutamate-stimulated calcium activation of Ras/Erk pathway mediated by nitric oxide. Diabetes Res Clin Pract. 45:1999;113.
46. Costa R.M., Federov N.B., Kogan J.H., et al. Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1. Nature. 415:2002;526.
47. Hebeiss K., Kilbinger H. Cholinergic, and GABAergic regulation of nitric oxide synthesis in the guinea pig ileum. Am J Physiol. 276:1999;G862.
48. Kendrick K.M., Guevara-Guzman R., Zorrilla J., et al. Formation of olfactory memories mediated by nitric oxide. Nature. 388:1997;670.
49. Arancio O., Kiebler M., Lee C.J., et al. Nitric oxide acts directly in the pre-synaptic neuron to produce long-term potentiation in cultured hippocampal neurons. Cell. 87:1996;1025.
50. Bliss T.V.P., Collingridge G.L. A synaptic model of memory long-term potentiation in the hippocampus . Nature. 361:1993;31.
51. Morris R.G.M. Synaptic plasticity and learning selective impairment of learning and blockage of long-term potentiation in vivo by N-methyl-D-aspartate receptor antagonist, AP5 . J Neurosci. 9:1989;3040.
52. Morris R.G.M., Anderson G.S., Lynch M., Baudry M. Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist AP5. Nature. 319:1986;774.
53. Das UN. Long-chain polyunsaturated fatty acids in growth and development of brain and memory. Nutrition 2003;19:62.
54. Mortensen E.L., Michaelsen K.F., Sanders S.A., Reinisch J.M. The association between duration of breastfeeding and adult intelligence. JAMA. 287:2002;2365.
55. Lauritzen I., Blondeau N., Heurteaux C., Widmann C., Romey G., Lazdunski M. Polyunsaturated fatty acids are potent neuroprotectors. EMBO J. 19:2000;1784.
56. Hasselmo M.E. Neuromodulation acetylcholine and memory consolidation . Trends Cogn Sci. 3:1999;351.
57. Lopez-Jaramillo P., Teran E. Improvement in functions of the central nervous system by estrogen replacement therapy might be related with an increased nitric oxide production. Endothelium. 6:1999;263.
58. Zhao W., Chen H., Xu H., et al. Brain insulin receptors and spatial memory. J Biol Chem. 274:1999;34893.
59. Das U.N. Alcohol consumption and risk of dementia. Lancet. 360:2002;490.
60. Das U.N. Possible beneficial action(s) of glucose-insulin-potassium regimen in acute myocardial infarction and inflammatory conditions a hypothesis . Diabetologia. 43:2000;1081.
61. Das U.N. Is insulin an anti-inflammatory molecule? Nutrition. 17:2001;409.
62. Warner L.C., Gack N., Egan S.E., Goldberg H.J., Weinberg R.A., Skorecki K.L. RAS is required for epidermal growth factor-stimulated arachidonic acid release in rat-1 fibroblasts. Oncogene. 8:1993;3249.
63. Price B.D., Morris J.D., Marshall C.J., Hall A. Stimulation of phosphatidylcholine hydrolysis, diacylglycerol release, and arachidonic acid production by oncogenic ras is a consequence of protein kinase C activation. J Biol Chem. 264:1989;16638.
64. Chopkin R.S., Jiang Y.H., Davidson L.A., Lupton J.R. Modulation of intracellular second messengers by dietary fat during colonic tumor development. Adv Exp Med Biol. 422:1997;85.
65. Palakurthi S.S., Fluckiger R., Aktas H., et al. Inhibition of translation initiation mediates the anticancer effect of the n-3 polyunsaturated fatty acid eicosapentaenoic acid. Cancer Res. 60:2000;2919.
66. Golubic M., Harwalkar J.A., Bryant S.S., Sundaram V., Jove R., Lee J.H. Differential regulation of neurofibromin and p120 GTPase activating protein by nutritionally relevant fatty acids. Nutr Cancer. 30:1998;97.
67. Nabekura J., Noguchi K., Witt M.-R., Nielsen M., Akaike N. Functional modulation of human recombinant γ-aminobutyric acid type A receptor by docosahexaenoic acid. J Biol Chem. 273:1998;11056.
68. Owens S.P., Innis S.M. Docosahexaenoic and arachidonic acid prevent a decrease in dopaminergic and serotoninergic neurotransmitters in frontal cortex caused by a linoleic and α-linolenic acid deficient diet in formula-fed piglets. J Nutr. 129:1999;2088.
69. Beattie E.C., Stellwagen D., Morishita W., et al. Control of synaptic strength by glial TNFα Science. 295:2002;2282.
70. Mazzoni I.E., Said F.A., Aloyz R., Miller F.D., Kaplan D. Ras regulates sympathetic neuron survival by suppressing the p53-mediated cell death pathway. J Neursci. 19:1999;9716.
71. Arbiser J.L., Moses M.A., Fernadez C.A., et al. Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways. Proc Natl Acad Sci USA. 94:1997;861.
72. Norrby K. Oral administration of a nitric oxide synthase inhibitor enhances de novo mammalian angiogenesis mediated by TNF-alpha, saline and mast-cell secretion. APMIS. 108:2000;496.
73. Kobayashi K., Arakawa T. Arachidonic acid cascade and gastric mucosal injury, protection, and healing topics of this decade . J Clin Gastroenterol. 21:(suppl 1):1995;S12.
74. Tsopanoglou N.E., Pipili-Synetos E., Maragoudakis M.E. Leukotrienes C4 and D4 promote angiogenesis via a receptor-mediated interaction. Eur J Pharmacol. 258:1994;151.
75. Bussolati B., Dunk C., Grohman M., Kontos C.D., Mason J., Ahmed A. Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide. Am J Physiol. 159:2001;993.
76. Papapetropoulos A., Gracia-Cardena G., Madri J.A., Sessa W.C. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J Clin Invest. 100:1997;3131.
77. Radak Z., Kaneko T., Tahara S., et al. Regular exercise improves cognitive function and decreases oxidative damage in rat brain. Neurochem Int. 38:2001;17.
78. Perrig-Chiello P., Perrig W.J., Ehrsam R., Satehelin H.B., Krings F. The effects of resistance training on well-being and memory in elderly volunteers. Age Ageing. 27:1998;469.
79. Das U.N. Is obesity an inflammatory condition? Nutrition. 17:2001;953.
80. Kyle D.J., Schaefer E., Patton G., Beiser A. Low serum docosahexaenoic acid is a significant risk factor for Alzheimer's disease. Lipids. 34:1999;S245.
81. Yehuda S., Carasso R.L. Modulation of learning, pain thresholds, and thermoregulation in the rat by preparations of free purified α-linolenic and linoleic acids determination of the optimal w3-to-w-6 ratio . Proc Natl Acad Sci USA. 90:1993;10345.
82. Makrides M., Neumann M., Simmer K., Pater J., Gibson R. Are long-chain polyunsaturated fatty acids essential nutrients in infancy? Lancet. 345:1995;1463.
83. Carlson S.E., Ford A.J., Werkman S.H., Peeples J.M., Koo W.W.K. Visual acuity and fatty acid status in term infants fed human milk and formulas with and without docosahexaenoate and arachidonate from egg yolk lecithin. Pediatr Res. 39:1996;882.
84. Agostoni C., Trojan S., Bellu R., Riva E., Giovannini M. Neurodevelopmental quotient of healthy term infants at 4 months and feeding practice the role of long-chain polyunsaturated fatty acids . Pediatr Res. 38:1995;262.
85. Birch E.E., Hoffman D.R., Uauy R., Birch D.G., Prestidge C. Visual acuity and the essentiality of docosahexaenoic acid and arachidonic acid in the diet of term infants. Pediatr Res. 44:1998;201.
86. -/- mice. Proc Natl Acad Sci USA. 96:1999;13995.
87. Clifford J.J., Drago J., Natoli A.L., et al. Essential fatty acids given from conception prevent topographies of motor deficit in a transgenic model of Huntington's disease. Neuroscience. 109:2002;81.
88. Puri B.K., Bydder G.M., Counsell S.J., et al. MRI and neuropsychological improvement in Huntington's disease following ethyl-EPA treatment. Neuroreport. 13:2002;1.
89. Vaddadi K.S., Soosai E., Chiu E., Dingjan P. A randomized, placebo-controlled, double blind study of treatment of Huntington's disease with unsaturated fatty acids. Clin Neurosci Neuropathol. 13:2002;29.